Literature DB >> 20031651

Lack of association between large angiographic late loss and low risk of in-stent thrombus: angioscopic comparison between paclitaxel- and sirolimus-eluting stents.

Masamichi Takano1, Masanori Yamamoto, Daisuke Murakami, Shigenobu Inami, Kentaro Okamatsu, Koji Seimiya, Takayoshi Ohba, Yoshihiko Seino, Kyoichi Mizuno.   

Abstract

BACKGROUND: It recently has been hypothesized that a larger late loss may have a protective role against stent thrombosis. The relationship between angiographic late loss and the presence of thrombus based on angioscopic findings within paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) was investigated in this study. METHODS AND
RESULTS: Prospective 6-month follow-up angiographic and angioscopic examinations were performed on 18 patients for PES and on 20 patients for SES. Late loss was measured by quantitative coronary angiography. Angioscopic neointimal stent coverage (NSC) grade was classified as follows: 0=uncovered struts without neointima, 1=visible struts through thin neointima, and 2=no visible struts. In each patient, maximum NSC, minimum NSC, and the existence of thrombus were evaluated. Late loss and maximum NSC were greater in PES than in SES (0.38+/-0.43 versus 0.10+/-0.23 mm; P=0.02 and P=0.0004, respectively). Late loss was correlated with maximum NSC (grade 0, 0.06+/-0.01 mm; grade 1, 0.10+/-0.05 mm; and grade 2, 0.48+/-0.46 mm), whereas there was no correlation between late loss and minimum NSC. The prevalence of patients with uncovered struts did not differ (44% of PES, 40% of SES; P=0.78). In-stent thrombus was found more frequently in PES than in SES (72% versus 40%, P=0.046) despite no occurrence of stent thrombosis. Only within PES were thrombi found in the segments of NSC grade 2 associated with large late loss.
CONCLUSIONS: The present study suggests that angiographic large late loss was not associated with a low risk of in-stent thrombus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20031651     DOI: 10.1161/CIRCINTERVENTIONS.108.769448

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  5 in total

1.  A higher colour grade yellow plaque was detected at one year after implantation of an everolimus-eluting stent than after a zotarolimus-eluting stent.

Authors:  Koshi Matsuo; Yasunori Ueda; Mayu Nishio; Akio Hirata; Mitsutoshi Asai; Takayoshi Nemoto; Ayaka Murakami; Kazunori Kashiwase; Kazuhisa Kodama
Journal:  Heart Asia       Date:  2013-09-07

2.  Serial endovascular assessment of polytetrafluoroethylene-covered stent: Capabilities and limitations of intravascular imaging modalities affected by a temporal factor.

Authors:  Takumi Kimura; Tomonori Itoh; Shoma Sugawara; Tetsuya Fusazaki; Motoyuki Nakamura; Yoshihiro Morino
Journal:  J Cardiol Cases       Date:  2014-12-19

3.  Serial angioscopic evaluation of neointimal coverage and incidence of thrombus formation after Paclitaxel-eluting stent implantation: comparison between 6- and 18-month follow-up.

Authors:  Masahiko Hara; Masami Nishino; Masayuki Taniike; Nobuhiko Makino; Hiroyasu Kato; Yasuyuki Egami; Ryu Shutta; Jun Tanouchi; Yoshio Yamada
Journal:  Clin Cardiol       Date:  2011-03-22       Impact factor: 2.882

4.  Procedural and 1-year outcomes following large vessel coronary artery perforation treated by covered stents implantation: Multicentre CRACK registry.

Authors:  Wojciech Wańha; Rafał Januszek; Michalina Kołodziejczak; Łukasz Kuźma; Mateusz Tajstra; Tomasz Figatowski; Malwina Smolarek-Nicpoń; Monika Gruz-Kwapisz; Brunon Tomasiewicz; Jerzy Bartuś; Andrzej Łoś; Dariusz Jagielak; Tomasz Roleder; Adrian Włodarczak; Jan Kulczycki; Mariusz Kowalewski; Damian Hudziak; Paweł Stachowiak; Jarosław Gorący; Katarzyna Sierakowska; Krzysztof Reczuch; Miłosz Jaguszewski; Sławomir Dobrzycki; Grzegorz Smolka; Stanisław Bartuś; Andrzej Ochała; Mariusz Gąsior; Wojciech Wojakowski
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

5.  Relationship between angiographic late loss and 5-year clinical outcome after drug-eluting stent implantation.

Authors:  Young-June Yang; Sanghoon Shin; Byeong-Keuk Kim; Jung-Sun Kim; Dong-Ho Shin; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.